Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease

Blood

Volumn 102, Issue 10, 2003, Pages 3793-3796

  Kralovics, Robert ^b   Stockton, David W ^b   Prchal, Josef T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BONE MARROW CELL; CELL PROLIFERATION; CHROMOSOME 13Q; CHROMOSOME 20Q; CHROMOSOME 9P; CLINICAL ARTICLE; CLONE; DISEASE PREDISPOSITION; ERYTHROID CELL; FAMILIAL DISEASE; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; HEMATOPOIESIS; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; PATHOGENESIS; PENETRANCE; POLYCYTHEMIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; STEM CELL;

EID: 0242493826     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0885     Document Type: Article

References (21)

1. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;295:913-916.
2. Prchal JF, Axelrad AA. Bone-marrow responses in polycythemia vera [letter]. N Engl J Med. 1974; 290:1382.
3. Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood. 1995;86:15-22.
4. Liu E, Jelinek J, Pastore YD, Guan Y, Prchal JF, Prchal JT. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 2003;101:3294-3301,
5. Shih LY, Lee CT. Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 1994;83:744-748.
6. Prchal JT. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. Semin Hematol. 2001;38:10-20.
7. Ratnoff WD, Gress RE. The familial occurrence of polycythemia vera: report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethylene, Blood. 1980;56:233-236.
8. Friedland ML, Wittels EG, Robinson RJ. Polycythemia vera in identical twins. Am J Hematol. 1981;10:101-103.
9. Inaba T, Shimazaki C, Hirai H, et al. Familial polycythemia vera in father and daughter [letter]. Am J Hematol. 1996;51:172.
10. Perez-Encinas M, Bello JL, Perez-Crespo S, De Miguel R, Tome S. Familial myeloproliferative syndrome. Am J Hematol. 1994;46:225-229.
11. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol. 1986;23:132-143.
12. Kralovics R, Guan Y, Prchal JT. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol. 2002;30:229-236.
13. Ang SO, Chen H, Gordeuk VR, et al. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis. 2002;28:57-62.
14. Sokol L, Prchal JT. Two microsatellite repeat polymorphisms in the EPO gene. Hum Mol Genet. 1994;3:219.
15. WiestnerA, Padosch SA, Ghilardi N, et al. Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia. BrJ Haematol. 2000;110:104-109.
16. Prchal JT, Prchal JF, Belickova M, et al. Clonal stability analysis of all blood lineages indicated by X-chromosomal transcriptional polymorphism. J Exp Med. 1996; 183:748-760.
17. Ploughman LM, Boehnke M. Estimating the power of a proposed linkage study for a complex genetic trait. Amer J Hum Genet, 1989;44:543-551.
18. Bench AJ, Aldred MA, Humphray SJ, et al. A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genomics. 1998;49:351-362.
19. Bench AJ, Nacheva EP, Champion KM, Green AR. Molecular genetics and cytogenetics of myeloproliferative disorders. Baillieres Clin Haematol. 1998;11:819-848.
20. Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera [see comments]. N Engl J Med. 1998;338:572-580.
21. Chiba S, Takahashi T, Takeshita K, et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood. 1997;90:97-104.